Differentiation of human innate lymphoid cells (ILCs)

Current Opinion in Immunology

Volumn 38, Issue , 2016, Pages 75-85

  Juelke, Kerstin ^a   Romagnani, Chiara ^a  

^a POTSDAM INSTITUTE FOR CLIMATE IMPACT RESEARCH PIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; CELL LINEAGE; DIFFERENTIATION; DNA TRANSCRIPTION; GENETIC TRANSCRIPTION; HUMAN VERSUS ANIMAL COMPARISON; LYMPHOID CELL; NONHUMAN; PLASTICITY; PRECURSOR; TRANSCRIPTION REGULATION; ANIMAL; ANTIBODY SPECIFICITY; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; INNATE IMMUNITY; LYMPHOCYTE; MOUSE; SIGNAL TRANSDUCTION;

INTERFERON; INTERLEUKIN DERIVATIVE; LEUKOCYTE ANTIGEN; TRANSCRIPTION FACTOR;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; INTERFERONS; INTERLEUKINS; LYMPHOCYTES; MICE; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84949921751     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.11.005     Document Type: Review

References (132)

1. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N.J., Mebius R.E., et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013, 13:145-149.
2. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975, 5:112-117.
3. Pross H.F., Jondal M. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol 1975, 21:226-235.
4. Kelly K.A., Scollay R. Seeding of neonatal lymph nodes by T cells and identification of a novel population of CD3-CD4+ cells. Eur J Immunol 1992, 22:329-334.
5. Mebius R.E., Rennert P., Weissman I.L. Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997, 7:493-504.
6. Jacobs R., Hintzen G., Kemper A., Beul K., Kempf S., Behrens G., Sykora K.W., Schmidt R.E. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001, 31:3121-3127.
7. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-3151.
8. Sojka D.K., Tian Z., Yokoyama W.M. Tissue-resident natural killer cells and their potential diversity. Semin Immunol 2014, 26:127-131.
9. Serafini N., Vosshenrich C.A.J., Di Santo J.P. Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol 2015, 15:415-428.
10. Shi F.-D., Ljunggren H.-G., La Cava A., Van Kaer L. Organ-specific features of natural killer cells. Nat Rev Immunol 2011, 11:658-671.
11. Fuchs A., Vermi W., Lee J.S., Lonardi S., Gilfillan S., Newberry R.D., Cella M., Colonna M. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity 2013, 38:769-781.
12. Bernink J.H., Peters C.P., Munneke M., te Velde A.A., Meijer S.L., Weijer K., Hreggvidsdottir H.S., Heinsbroek S.E., Legrand N., Buskens C.J., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013, 14:221-229.
13. Marquardt N., Béziat V., Nyström S., Hengst J., Ivarsson M.A., Kekäläinen E., Johansson H., Mjösberg J., Westgren M., Lankisch T.O., et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol 2015, 194:2467-2471.
14. Vacca P., Montaldo E., Croxatto D., Loiacono F., Canegallo F., Venturini P.L., Moretta L., Mingari M.C. Identification of diverse innate lymphoid cells in human decidua. Mucosal Immunol 2015, 8:254-264.
15. Villanova F., Flutter B., Tosi I., Grys K., Sreeneebus H., Perera G.K., Chapman A., Smith C.H., Di Meglio P., Nestle F.O. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 2014, 134:984-991.
16. Kupz A., Scott T.A., Belz G.T., Andrews D.M., Greyer M., Lew A.M., Brooks A.G., Smyth M.J., Curtiss R., Bedoui S., et al. Contribution of Thy1+ NK cells to protective IFN-γ production during Salmonella typhimurium infections. Proc Natl Acad Sci U S A 2013, 110:2252-2257.
17. Klose C.S.N., Flach M., Möhle L., Rogell L., Hoyler T., Ebert K., Fabiunke C., Pfeifer D., Sexl V., Fonseca-Pereira D., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014, 157:340-356.
18. Wensveen F.M., Jelenčić V., Valentić S., Šestan M., Wensveen T.T., Theurich S., Glasner A., Mendrila D., Štimac D., WunderlichF F.T., et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol 2015, 16:376-385.
19. Moffett A., Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest 2014, 124:1872-1879.
20. McKenzie A.N.J., Spits H., Eberl G. Innate lymphoid cells in inflammation and immunity. Immunity 2014, 41:366-374.
21. Price A.E., Liang H.-E., Sullivan B.M., Reinhardt R.L., Eisley C.J., Erle D.J., Locksley R.M. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 2010, 107:11489-11494.
22. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., Furusawa J.-I., Ohtani M., Fujii H., Koyasu S. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
23. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K.A., Bucks C., Kane C.M., Fallon P.G., Pannell R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
24. Mjösberg J., Bernink J., Golebski K., Karrich J.J., Peters C.P., Blom B., te Velde A.A., Fokkens W.J., van Drunen C.M., Spits H. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012, 37:649-659.
25. Teunissen M.B.M., Munneke J.M., Bernink J.H., Spuls P.I., Res P.C.M., Te Velde A., Cheuk S., Brouwer M.W.D., Menting S.P., Eidsmo L., et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 2014, 134:2351-2360.
26. Walker J.A., McKenzie A.N.J. Development and function of group 2 innate lymphoid cells. Curr Opin Immunol 2013, 25:148-155.
27. Bernink J.H., Germar K., Spits H. The role of ILC2 in pathology of type 2 inflammatory diseases. Curr Opin Immunol 2014, 31:115-120.
28. Hoyler T., Klose C.S.N., Souabni A., Turqueti A., Pfeifer D., Rawlins E.L., Voehringer D., Busslinger M., Turqueti-Neves A., Diefenbach A. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 2012, 37:634-648.
29. Kim B.S., Siracusa M.C., Saenz S.A., Noti M., Monticelli L.A., Sonnenberg G.F., Hepworth M.R., Van Voorhees A.S., Comeau M.R., Artis D. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013, 5. 170ra16.
30. Mjösberg J.M., Trifari S., Crellin N.K., Peters C.P., van Drunen C.M., Piet B., Fokkens W.J., Cupedo T., Spits H. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011, 12:1055-1062.
31. Monticelli L.A., Sonnenberg G.F., Abt M.C., Alenghat T., Ziegler C.G.K., Doering T.A., Angelosanto J.M., Laidlaw B.J., Yang C.Y., Sathaliyawala T., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011, 12:1045-1054.
32. Tait Wojno E.D., Monticelli L.A., Tran S.V., Alenghat T., Osborne L.C., Thome J.J., Willis C., Budelsky A., Farber D.L., Artis D. The prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. Mucosal Immunol 2015, [no volume].
33. Dyring-Andersen B., Geisler C., Agerbeck C., Lauritsen J.P.H., Gúdjonsdottir S.D., Skov L., Bonefeld C.M. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol 2014, 170:609-616.
34. Brestoff J.R., Kim B.S., Saenz S.A., Stine R.R., Monticelli L.A., Sonnenberg G.F., Thome J.J., Farber D.L., Lutfy K., Seale P., et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015, 519:242-246.
35. Hams E., Armstrong M.E., Barlow J.L., Saunders S.P., Schwartz C., Cooke G., Fahy R.J., Crotty T.B., Hirani N., Flynn R.J., et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci U S A 2014, 111:367-372.
36. Salimi M., Barlow J.L., Saunders S.P., Xue L., Gutowska-Owsiak D., Wang X., Huang L.-C., Johnson D., Scanlon S.T., McKenzie A.N.J., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013, 210:2939-2950.
37. Glatzer T., Killig M., Meisig J., Ommert I., Luetke-Eversloh M., Babic M., Paclik D., Blüthgen N., Seidl R., Seifarth C., et al. RORγt+ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 2013, 38:1223-1235.
38. Crellin N.K., Trifari S., Kaplan C.D., Cupedo T., Spits H. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med 2010, 207:281-290.
39. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., Fibbe W.E., Cornelissen J.J., Spits H. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009, 10:66-74.
40. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K.M., Doherty J.M., Mills J.C., Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
41. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., Hardwigsen J., Anguiano E., Banchereau J., Chaussabel D., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2009, 10:75-82.
42. Satoh-Takayama N., Vosshenrich C.A.J., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention J.-J., Thiam K., Cerf-Bensussan N., Mandelboim O., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
43. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009, 10:83-91.
44. Sonnenberg G.F., Monticelli L.A., Elloso M.M., Fouser L.A., Artis D. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011, 34:122-134.
45. Crellin N.K., Trifari S., Kaplan C.D., Satoh-Takayama N., Di Santo J.P., Spits H. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 2010, 33:752-764.
46. Fukuyama S., Hiroi T., Yokota Y., Rennert P.D., Yanagita M., Kinoshita N., Terawaki S., Shikina T., Yamamoto M., Kurono Y., et al. Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells. Immunity 2002, 17:31-40.
47. Finke D., Acha-Orbea H., Mattis A., Lipp M., Kraehenbuhl J. CD4+CD3- cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. Immunity 2002, 17:363-373.
48. Finke D. Fate and function of lymphoid tissue inducer cells. Curr Opin Immunol 2005, 17:144-150.
49. Spits H., Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012, 30:647-675.
50. Sonnenberg G.F., Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012, 37:601-610.
51. Magri G., Miyajima M., Bascones S., Mortha A., Puga I., Cassis L., Barra C.M., Comerma L., Chudnovskiy A., Gentile M., et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol 2014, 15:354-364.
52. Kim H.Y., Lee H.J., Chang Y.-J., Pichavant M., Shore S.A., Fitzgerald K.A., Iwakura Y., Israel E., Bolger K., Faul J., et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 2014, 20:54-61.
53. Hoorweg K., Peters C.P., Cornelissen F., Aparicio-Domingo P., Papazian N., Kazemier G., Mjösberg J.M., Spits H., Cupedo T. Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells. Front Immunol 2012, 3:72.
54. Doulatov S., Notta F., Laurenti E., Dick J.E. Hematopoiesis: a human perspective. Cell Stem Cell 2012, 10:120-136.
55. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
56. Cherrier M., Sawa S., Eberl G. Notch, Id2, and RORγt sequentially orchestrate the fetal development of lymphoid tissue inducer cells. J Exp Med 2012, 209:729-740.
57. Yoshida H., Kawamoto H., Santee S.M., Hashi H., Honda K., Nishikawa S., Ware C.F., Katsura Y., Nishikawa S.I. Expression of alpha(4)beta(7) integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J Immunol 2001, 167:2511-2521.
58. Yu X., Wang Y., Deng M., Li Y., Ruhn K.A., Zhang C.C., Hooper L.V. The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. Elife 2014, 3.
59. Yang Q., Li F., Harly C., Xing S., Ye L., Xia X., Wang H., Wang X., Yu S., Zhou X., et al. TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow. Nat Immunol 2015, [no volume].
60. Di Santo J.P. Staying innate: transcription factor maintenance of innate lymphoid cell identity. Immunol Rev 2014, 261:169-176.
61. Seehus C.R., Aliahmad P., de la Torre B., Iliev I.D., Spurka L., Funari V.A., Kaye J. The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor. Nat Immunol 2015, 16:599-608.
62. Aliahmad P., de la Torre B., Kaye J. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat Immunol 2010, 11:945-952.
63. Constantinides M.G., McDonald B.D., Verhoef P.A., Bendelac A. A committed precursor to innate lymphoid cells. Nature 2014, 508:397-401.
64. Galy A., Travis M., Cen D., Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995, 3:459-473.
65. Six E.M., Bonhomme D., Monteiro M., Beldjord K., Jurkowska M., Cordier-Garcia C., Garrigue A., Dal Cortivo L., Rocha B., Fischer A., et al. A human postnatal lymphoid progenitor capable of circulating and seeding the thymus. J Exp Med 2007, 204:3085-3093.
66. Hoebeke I., De Smedt M., Stolz F., Pike-Overzet K., Staal F.J.T., Plum J., Leclercq G. T-B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(-)CD7(+) common lymphoid progenitors expressing lymphoid-specific genes. Leukemia 2007, 21:311-319.
67. Hao Q.L., Zhu J., Price M.A., Payne K.J., Barsky L.W., Crooks G.M. Identification of a novel, human multilymphoid progenitor in cord blood. Blood 2001, 97:3683-3690.
68. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 2010, 11:585-593.
69. Wu C., Li B., Lu R., Koelle S.J., Yang Y., Jares A., Krouse A.E., Metzger M., Liang F., Loré K., et al. Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell 2014, 14:486-499.
70. Tang Q., Ahn Y.-O., Southern P., Blazar B.R., Miller J.S., Verneris M.R. Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue. Blood 2011, 117:4052-4055.
71. Gentek R., Munneke J.M., Helbig C., Blom B., Hazenberg M.D., Spits H., Amsen D. Modulation of signal strength switches notch from an inducer of T cells to an inducer of ILC2. Front Immunol 2013, 4:334.
72. Montaldo E., Teixeira-Alves L.G., Glatzer T., Durek P., Stervbo U., Hamann W., Babic M., Paclik D., Stölze K.L., Gröne J., et al. Human RORγt+CD34+ cells are lineage-specified progenitors of group 3 RORγt+ innate lymphoid cells. Immunity 2014, 44.
73. Renoux V.M., Zriwil A., Peitzsch C., Michaëlsson J., Friberg D., Soneji S., Sitnicka E. Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues. Immunity 2015, 43:394-407.
74. Freud A.G., Becknell B., Roychowdhury S., Mao H.C., Ferketich A.K., Nuovo G.J., Hughes T.L., Marburger T.B., Sung J., Baiocchi R.A., et al. A human CD34 (+) subset resides in lymph nodes and differentiates into CD56 bright natural killer cells. Immunity 2005, 22:295-304.
75. Canque B., Camus S., Dalloul A., Kahn E., Yagello M., Dezutter-Dambuyant C., Schmitt D., Schmitt C., Gluckman J.C. Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells. Blood 2000, 96:3748-3756.
76. Freud A.G., Yokohama A., Becknell B., Lee M.T., Mao H.C., Ferketich A.K., Caligiuri M.A. Evidence for discrete stages of human natural killer cell diff erentiation in vivo. J Exp Med 2006, 203.
77. Constantinides M.G., Gudjonson H., McDonald B.D., Ishizuka I.E., Verhoef P.A., Dinner A.R., Bendelac A. PLZF expression maps the early stages of ILC1 lineage development. Proc Natl Acad Sci U S A 2015, 112:5123-5128.
78. Carotta S., Pang S.H.M., Nutt S.L., Belz G.T. Identification of the earliest NK-cell precursor in the mouse BM. Blood 2011, 117:5449-5452.
79. Fathman J.W., Bhattacharya D., Inlay M.A., Seita J., Karsunky H., Weissman I.L. Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood 2011, 118:5439-5447.
80. McClory S., Hughes T., Freud A.G., Briercheck E.L., Martin C., Trimboli A.J., Yu J., Zhang X., Leone G., Nuovo G., et al. Evidence for a stepwise program of extrathymic T cell development within the human tonsil. J Clin Invest 2012, 122:1403-1415.
81. Res P., Martínez-Cáceres E., Cristina Jaleco A., Staal F., Noteboom E., Weijer K., Spits H. CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood 1996, 87:5196-5206.
82. Moroso V., Famili F., Papazian N., Cupedo T., van der Laan L.J.W., Kazemier G., Metselaar H.J., Kwekkeboom J. NK cells can generate from precursors in the adult human liver. Eur J Immunol 2011, 41:3340-3350.
83. Yu J., Freud A.G., Caligiuri M.A. Location and cellular stages of natural killer cell development. Trends Immunol 2013, 34:573-582.
84. Gordon S.M., Chaix J., Rupp L.J., Wu J., Madera S., Sun J.C., Lindsten T., Reiner S.L. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012, 36:55-67.
85. Daussy C., Faure F., Mayol K., Viel S., Gasteiger G., Charrier E., Bienvenu J., Henry T., Debien E., Hasan U.A., et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med 2014, 211:563-577.
86. Pearce E.L., Mullen A.C., Martins G.A., Krawczyk C.M., Hutchins A.S., Zediak V.P., Banica M., DiCioccio C.B., Gross D.A., Mao C.-A., et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 2003, 302:1041-1043.
87. Luetke-Eversloh M., Cicek B.B., Siracusa F., Thom J.T., Hamann A., Frischbutter S., Baumgrass R., Chang H.-D., Thiel A., Dong J., et al. NK cells gain higher IFN-γ competence during terminal differentiation. Eur J Immunol 2014, 44:2074-2084.
88. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998, 9:669-676.
89. Sojka D.K., Plougastel-Douglas B., Yang L., Pak-Wittel M.A., Artyomov M.N., Ivanova Y., Zhong C., Chase J.M., Rothman P.B., YuF J., et al. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife 2014, 3:e01659.
90. Ahn Y.-O., Blazar B.R., Miller J.S., Verneris M.R. Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells. Blood 2013, 121:2234-2243.
91. Mrózek E., Anderson P., Caligiuri M.A. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996, 87:2632-2640.
92. Wong S.H., Walker J.A., Jolin H.E., Drynan L.F., Hams E., Camelo A., Barlow J.L., Neill D.R., Panova V., Koch U., et al. Transcription factor RORα is critical for nuocyte development. Nat Immunol 2012, 13:229-236.
93. Yang Q., Saenz S.A., Zlotoff D.A., Artis D., Bhandoola A. Cutting edge: natural helper cells derive from lymphoid progenitors. J Immunol 2011, 187:5505-5509.
94. Klein Wolterink R.G.J., Serafini N., van Nimwegen M., Vosshenrich C.A.J., de Bruijn M.J.W., Fonseca Pereira D., Veiga Fernandes H., Hendriks R.W., Di Santo J.P. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proc Natl Acad Sci U S A 2013, 110:10240-10245.
95. Halim T.Y.F., MacLaren A., Romanish M.T., Gold M.J., McNagny K.M., Takei F. Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 2012, 37:463-474.
96. Spooner C.J., Lesch J., Yan D., Khan A.A., Abbas A., Ramirez-Carrozzi V., Zhou M., Soriano R., Eastham-Anderson J., Diehl L., et al. Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nat Immunol 2013, 14:1229-1236.
97. Califano D., Cho J.J., Uddin M.N., Lorentsen K.J., Yang Q., Bhandoola A., Li H., Avram D. Transcription factor Bcl11b controls identity and function of mature type 2 innate lymphoid cells. Immunity 2015, [no volume].
98. Yu Y., Wang C., Clare S., Wang J., Lee S.-C., Brandt C., Burke S., Lu L., He D., Jenkins N.A., et al. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development. J Exp Med 2015, 212:865-874.
99. Walker J.A., Oliphant C.J., Englezakis A., Yu Y., Clare S., Rodewald H.-R., Belz G., Liu P., Fallon P.G., McKenzie A.N.J. Bcl11b is essential for group 2 innate lymphoid cell development. J Exp Med 2015, 212:875-882.
100. Yang Q., Monticelli L.A., Saenz S.A., Chi A.W.-S., Sonnenberg G.F., Tang J., De Obaldia M.E., Bailis W., Bryson J.L., Toscano K., et al. T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 2013, 38:694-704.
101. Eberl G., Marmon S., Sunshine M.-J., Rennert P.D., Choi Y., Littman D.R. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004, 5:64-73.
102. Satoh-Takayama N., Lesjean-Pottier S., Vieira P., Sawa S., Eberl G., Vosshenrich C.A.J., Di Santo J.P. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 2010, 207:273-280.
103. Possot C., Schmutz S., Chea S., Boucontet L., Louise A., Cumano A., Golub R. Notch signaling is necessary for adult, but not fetal, development of RORγt(+) innate lymphoid cells. Nat Immunol 2011, 12:949-958.
104. Chappaz S., Gärtner C., Rodewald H.-R., Finke D. Kit ligand and Il7 differentially regulate Peyer's patch and lymph node development. J Immunol 2010, 185:3514-3519.
105. Montaldo E., Juelke K., Romagnani C. Group 3 innate lymphoid cells (ILC3s): origin, differentiation and plasticity in humans and mice. Eur J Immunol 2015, [no volume].
106. Rankin L.C., Groom J.R., Chopin M., Herold M.J., Walker J.A., Mielke L.A., McKenzie A.N.J., Carotta S., Nutt S.L., Belz G.T. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat Immunol 2013, 14:389-395.
107. Kiss E.A., Vonarbourg C., Kopfmann S., Hobeika E., Finke D., Esser C., Diefenbach A. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
108. Lee J.S., Cella M., McDonald K.G., Garlanda C., Kennedy G.D., Nukaya M., Mantovani A., Kopan R., Bradfield C.A., Newberry R.D., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 2012, 13:144-151.
109. Qiu J., Heller J.J., Guo X., Chen Z.E., Fish K., Fu Y.-X., Zhou L. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012, 36:92-104.
110. Hughes T., Briercheck E.L., Freud A.G., Trotta R., McClory S., Scoville S.D., Keller K., Deng Y., Cole J., Harrison N., et al. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Cell Rep 2014, 8:150-162.
111. van de Pavert S.A., Ferreira M., Domingues R.G., Ribeiro H., Molenaar R., Moreira-Santos L., Almeida F.F., Ibiza S., Barbosa I., Goverse G., et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 2014, 508:123-127.
112. Spencer S.P., Wilhelm C., Yang Q., Hall J.A., Bouladoux N., Boyd a., Nutman T.B., Urban J.F., Wang J., Ramalingam T.R., et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 2014, 343:432-437.
113. Ghiaur G., Yegnasubramanian S., Perkins B., Gucwa J.L., Gerber J.M., Jones R.J. Regulation of human hematopoietic stem cell self-renewal by the microenvironment's control of retinoic acid signaling. Proc Natl Acad Sci U S A 2013, 110:16121-16126.
114. Vonarbourg C., Mortha A., Bui V.L., Hernandez P.P., Kiss E.A., Hoyler T., Flach M., Bengsch B., Thimme R., Hölscher C., et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity 2010, 33:736-751.
115. Cella M., Otero K., Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci U S A 2010, 107:10961-10966.
116. Hughes T., Becknell B., Freud A.G., McClory S., Briercheck E., Yu J., Mao C., Giovenzana C., Nuovo G., Wei L., et al. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010, 32:803-814.
117. Bernink J.H., Krabbendam L., Germar K., de Jong E., Gronke K., Kofoed-Nielsen M., Munneke J.M., Hazenberg M.D., Villaudy J., Buskens C.J., et al. Interleukin-12 and -23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 2015, 43:146-160.
118. Huang Y., Guo L., Qiu J., Chen X., Hu-Li J., Siebenlist U., Williamson P.R., Urban J.F., Paul W.E. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential "inflammatory" type 2 innate lymphoid cells. Nat Immunol 2015, 16:161-169.
119. Nagler A., Lanier L.L., Cwirla S., Phillips J.H. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989, 143:3183-3191.
120. Hughes T., Briercheck E.L., Freud A.G., Trotta R., McClory S., Scoville S.D., Keller K., Deng Y., Cole J., Harrison N., et al. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Cell Rep 2014, 8:150-162.
121. Salimi M., Xue L., Jolin H., Hardman C., Cousins D.J., McKenzie A.N.J., Ogg G.S. Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production. J Immunol 2015, [no volume].
122. Takayama T., Kamada N., Chinen H., Okamoto S., Kitazume M.T., Chang J., Matuzaki Y., Suzuki S., Sugita A., Koganei K., et al. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology 2010, 139:882-892. 892.e1-3.
123. Munneke J.M., Björklund A.T., Mjösberg J.M., Garming-Legert K., Bernink J.H., Blom B., Huisman C., van Oers M.H.J., Spits H., Malmberg K.-J., et al. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood 2014, 124:812-821.
124. Ebert L.M., Meuter S., Moser B. Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol 2006, 176:4331-4336.
125. Schierloh P., Yokobori N., Alemán M., Musella R.M., Beigier-Bompadre M., Saab M.A., Alves L., Abbate E., de la Barrera S.S., Sasiain M.C. Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-gamma-producing CD56bright cells in tuberculous pleurisy. J Immunol 2005, 175:6852-6860.
126. Doherty D.G., Norris S., Madrigal-Estebas L., McEntee G., Traynor O., Hegarty J.E., O'Farrelly C. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999, 163:2314-2321.
127. Hata K., Van Thiel D.H., Herberman R.B., Whiteside T.L. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology 1992, 15:816-823.
128. Moroso V., Metselaar H.J., Mancham S., Tilanus H.W., Eissens D., van der Meer A., van der Laan L.J.W., Kuipers E.J., Joosten I., Kwekkeboom J. Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transpl 2010, 16:895-908.
129. Bulmer J.N., Lash G.E. Human uterine natural killer cells: a reappraisal. Mol Immunol 2005, 42:511-521.
130. Flynn L., Byrne B., Carton J., Kelehan P., O'Herlihy C., O'Farrelly C. Menstrual cycle dependent fluctuations in NK and T-lymphocyte subsets from non-pregnant human endometrium. Am J Reprod Immunol 2000, 43:209-217.
131. Male V., Hughes T., McClory S., Colucci F., Caligiuri M.A., Moffett A. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J Immunol 2010, 185:3913-3918.
132. O'Rourke R.W., Gaston G.D., Meyer K.A., White A.E., Marks D.L. Adipose tissue NK cells manifest an activated phenotype in human obesity. Metabolism 2013, 62:1557-1561.